Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posoleucel in kidney transplant recipients with BK viremia
NCT04605484Phase 2Completed
- Sponsor
- AlloVir
- Start
- Mar 2021
- Primary completion
- Oct 2022
- Modality
- Native Immune Cells
- Countries
- 1
01
Overview
A Phase 2 trial of posoleucel in BK virus infection, BK virus nephropathy (BKVN), sponsored by AlloVir. Started Mar 2021; status: completed.
02
Drugs
posoleucel
03
Conditions
BK virus infectionBK virus nephropathy (BKVN)
Beyond the preview
Go deeper on NCT04605484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04605484.